12-111466567-T-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001372574.1(ATXN2):​c.2843-1852A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.668 in 152,184 control chromosomes in the GnomAD database, including 37,051 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.67 ( 37051 hom., cov: 33)

Consequence

ATXN2
NM_001372574.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.121

Publications

110 publications found
Variant links:
Genes affected
ATXN2 (HGNC:10555): (ataxin 2) This gene belongs to a group of genes that is associated with microsatellite-expansion diseases, a class of neurological and neuromuscular disorders caused by expansion of short stretches of repetitive DNA. The protein encoded by this gene has two globular domains near the N-terminus, one of which contains a clathrin-mediated trans-Golgi signal and an endoplasmic reticulum exit signal. The encoded cytoplasmic protein localizes to the endoplasmic reticulum and plasma membrane, is involved in endocytosis, and modulates mTOR signals, modifying ribosomal translation and mitochondrial function. The N-terminal region of the protein contains a polyglutamine tract of 14-31 residues that can be expanded in the pathogenic state to 32-200 residues. Intermediate length expansions of this tract increase susceptibility to amyotrophic lateral sclerosis, while long expansions of this tract result in spinocerebellar ataxia-2, an autosomal-dominantly inherited, neurodegenerative disorder. Genome-wide association studies indicate that loss-of-function mutations in this gene may be associated with susceptibility to type I diabetes, obesity and hypertension. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
ATXN2 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.975 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001372574.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATXN2
NM_001372574.1
MANE Select
c.2843-1852A>T
intron
N/ANP_001359503.1
ATXN2
NM_002973.4
c.2837-1852A>T
intron
N/ANP_002964.4
ATXN2
NM_001310121.1
c.2522-1852A>T
intron
N/ANP_001297050.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATXN2
ENST00000673436.1
MANE Select
c.2843-1852A>T
intron
N/AENSP00000500925.1
ATXN2
ENST00000550104.5
TSL:1
c.3317-1852A>T
intron
N/AENSP00000446576.2
ATXN2
ENST00000608853.5
TSL:1
c.2837-1852A>T
intron
N/AENSP00000476504.1

Frequencies

GnomAD3 genomes
AF:
0.668
AC:
101562
AN:
152066
Hom.:
36978
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.916
Gnomad AMI
AF:
0.542
Gnomad AMR
AF:
0.703
Gnomad ASJ
AF:
0.330
Gnomad EAS
AF:
0.998
Gnomad SAS
AF:
0.903
Gnomad FIN
AF:
0.573
Gnomad MID
AF:
0.614
Gnomad NFE
AF:
0.502
Gnomad OTH
AF:
0.640
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.668
AC:
101699
AN:
152184
Hom.:
37051
Cov.:
33
AF XY:
0.680
AC XY:
50546
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.916
AC:
38086
AN:
41570
American (AMR)
AF:
0.703
AC:
10754
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.330
AC:
1144
AN:
3468
East Asian (EAS)
AF:
0.998
AC:
5180
AN:
5190
South Asian (SAS)
AF:
0.903
AC:
4355
AN:
4824
European-Finnish (FIN)
AF:
0.573
AC:
6052
AN:
10562
Middle Eastern (MID)
AF:
0.612
AC:
180
AN:
294
European-Non Finnish (NFE)
AF:
0.502
AC:
34100
AN:
67966
Other (OTH)
AF:
0.643
AC:
1354
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1519
3039
4558
6078
7597
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
774
1548
2322
3096
3870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.542
Hom.:
13271
Bravo
AF:
0.684
Asia WGS
AF:
0.940
AC:
3267
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
1.8
DANN
Benign
0.75
PhyloP100
0.12
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4766578; hg19: chr12-111904371; API